|Bid||16.21 x 0|
|Ask||16.18 x 0|
|Day's Range||0.00 - 0.00|
|52 Week Range|
|Beta (5Y Monthly)||0.83|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 31, 2021 - Jun 04, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Dec 27, 2018|
|1y Target Est||25.12|
A robot armed with virus-killing ultraviolet light is being tested on Swiss airplanes, yet another idea aiming to restore passenger confidence and spare the travel industry more pandemic pain. UVeya, a Swiss start-up, is conducting the trials of the robots with Dubai-based airport services company Dnata inside Embraer jets from Helvetic Airways, a charter airline owned by Swiss billionaire Martin Ebner. Aircraft makers still must certify the devices and are studying the impact their UV light may have on interior upholstery, which could fade after many disinfections, UVeya co-founder Jodoc Elmiger said.
Embraer's (ERJ) Q4 adjusted loss of 7 cents per American Depository Share (ADS) marks an improvement from the year-ago quarter's adjusted loss of 51 cents.
Shares of Embraer SA jumped 6.8% after the Brazilian aerospace conglomerate reported a better-than-expected loss in the fourth quarter and surpassed analysts’ expectations for revenues. Embraer (ERJ) incurred a loss of $0.07 per share in 4Q, compared to the $0.32 loss per share estimated by analysts and $0.81 per share reported in the prior-year quarter. Total revenue came in at $1.84 billion, topping analysts’ expectations of $1.66 billion but declining 11.7% year-over-year. Growth in the defense & security segment was fully mitigated by revenue declines in commercial aviation, executive jets, and services & support segments. The company’s adjusted EBITDA was $145.6 million in the quarter, up from $65.8 million in the same quarter last year. In 4Q, Embraer delivered 28 commercial jets and 43 executive jets. (See Embraer stock analysis on TipRanks) Cowen & Co. analyst Cai Rumohr maintained a Hold rating and a price target of $7 (34.5% downside potential) based on the company’s “better than expected” 4Q results. Overall, the stock has a Moderate Sell consensus rating based on 2 Holds versus 1 Sell. The average analyst price target of $6 implies 43.8% downside potential from current levels. Related News: FedEx Posts Better-Than-Expected 3Q Results As Sales Outperform; Shares Gain 4.4% Ollie’s 4Q Results Beat Analysts’ Expectations As Sales Pick Up; Shares Gain After-Hours Kiniksa Wins FDA Nod For ARCALYST Injection therapy; Shares Pop After-Hours More recent articles from Smarter Analyst: Hartford Receives Takeover Bid From Chubb Enova Snaps Up Pangea Universal Holdings Canadian Pacific Inks $29B Deal To Acquire Kansas City Southern Blackstone Bids To Snap Up Australian Casino Operator Crown Resorts